Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast to 2021

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost-effective testing.

The global molecular diagnostics market is projected to reach more than US$ 30 Billion by 2021The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market

Get Free Sample Copy of This Report @ https://www.4arcresearch.com/request-sample-275

North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. North America controls more than 40% of the market share by the year 2021. Japan, China and India is expected to show high growth rates in the next six years in molecular diagnostics market.

On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment. Oncology test controls nearly 25% market share by the year 2021.
Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market.

Get 30% Discount Coupon For This Report @ https://www.4arcresearch.com/request-sample-275

In terms of technology, Biochips/Microarrays is the fastest growing segment and is expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years.

On the basis of company, Roche is the leading company with more than 30% market share in the global molecular diagnostics market and is expected to hold its strong position in the market. Becton Dickinson, Myriad Genetics, Abbott and Qiagen is expected to robust market growth in the global molecular diagnostics market.

The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics Sales & Forecast 6) Market Growth Drivers & Challenges

Contact Us
4ARC Insights, Inc.
Email-sales@4arcresearch.com
Tel-+917498085685
Website - www.4arcresearch.com

4Arc Insights, Inc., is a pioneering market research and consulting firm based in Pune which is dedicated in providing reports on syndicated market research and customised market research. We leave no stone unturned while following smart study of the public demands, capabilities and the continuous growth of the working industry, interactive environment between the client-server, dynamic reporting, and high data protection services.

4ARC Insights, Inc.
Email-sales@4arcresearch.com
Tel-+917498085685

This release was published on openPR.